Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits <em>in vivo</em> anti-tumoral effects in immunocompetent mouse tumor models

Publication date: Available online 3 April 2023Source: Cancer LettersAuthor(s): Y. Morera-Díaz, C. Canaán-Haden, J. Sánchez-RamÍrez, M. Bequet-Romero, I. Gonzalez-Moya, R. Martínez, V. Falcón, D. Palenzuela, M. Ayala-Ávila, J.V. Gavilondo